Comments for Access Pharma (OTC: ACCP.OB): MuGard, Pipeline Makes for Appealing Acquisition Possibilities at http://www.biomedreports.com , comment 1 to 4 out of 4 comments http://www.biomedreports.com Wed, 08 Feb 2012 17:47:00 +0100 FeedCreator 1.7.3 http://www.biomedreports.com/2009092911214/access-pharma-otc-accpob-mugard-pipeline-makes-for-appealing-acquisition-possibilities.html#comment-955 Mike, do you know what happened to Sep 30th date when ACCP was suppose to disclose the full data of MuGard? I am now wondering if data was not as good as expected so company is doing some extensive testing? - sumesh Wed, 30 Sep 2009 14:42:37 +0100 http://www.biomedreports.com/2009092911214/access-pharma-otc-accpob-mugard-pipeline-makes-for-appealing-acquisition-possibilities.html#comment-948 I couldnt Agree more. I have been quite a few in and out and missed out the big moves, now I dont make that mistake. I am focusing on microcap now with total shares float of less than 20 million - sumesh Tue, 29 Sep 2009 23:14:59 +0100 http://www.biomedreports.com/2009092911214/access-pharma-otc-accpob-mugard-pipeline-makes-for-appealing-acquisition-possibilities.html#comment-947 i thought Mike H has gone off on his own.... advise - robert11 Tue, 29 Sep 2009 19:33:33 +0100 http://www.biomedreports.com/2009092911214/access-pharma-otc-accpob-mugard-pipeline-makes-for-appealing-acquisition-possibilities.html#comment-941 We must take into account that less than 1 out of a 100 micro cap biotechnology stocks make the grade, but when they do the reward is huge.If one understands the process and technology and has patience, it is a very lucrative field ! FJO MD. - Frederick Oddi MD. Tue, 29 Sep 2009 08:51:10 +0100